0000874015-23-000176.txt : 20230719 0000874015-23-000176.hdr.sgml : 20230719 20230719180555 ACCESSION NUMBER: 0000874015-23-000176 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 231097706 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-07-17 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001206369 KLEIN JOSEPH III 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 0 Common Stock 2023-07-17 4 M 0 1777 0.0 A 18568 D Common Stock 2023-07-17 4 M 0 5333 0.0 A 23901 D Common Stock 2023-07-18 4 S 0 3555 42.0 D 20346 D Common Stock 100 I by Son Common Stock 6000 I by Trust Restricted Stock Unit 0.0 2023-07-17 4 M 0 1777 0.0 D Common Stock 1777 10010 D Restricted Stock Unit 0.0 2023-07-17 4 M 0 5333 0.0 D Common Stock 5333 4677 D Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 17, 2022 The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. By: Patrick R. O'Neil, attorney-in-fact For: Joseph Klein III 2023-07-19